The inhibitory effect of ginsan on TGF-β mediated fibrotic process

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1241-1247

  Ahn, Ji Yeon ^a   Kim, Mi Hyoung ^a,b   Lim, Min Jin ^a   Park, Sarah ^a,b   Lee, Sae lo oom ^a   Yun, Yeon Sook ^a   Song, Jie Young ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN TYPE 1; FIBRONECTIN; GINSENG EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACTINS; ANIMALS; BLEOMYCIN; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FIBRONECTINS; FIBROSIS; GENES, REPORTER; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; PHOSPHORYLATION; POLYSACCHARIDES; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY FIBROSIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

MURINAE; PANAX GINSENG;

EID: 79951798852     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22452     Document Type: Article

References (33)

1. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272: 27678-27685.
2. Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, Jeong G, Song JY. 2006. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting toll-like receptor-mediated inflammatory signals. Eur J Immunol 36: 37-45.
3. Ahn JY, Park S, Yun YS, Song JY. 2010. Inhibition of type III TGF-beta receptor aggravates lung fibrotic process. Biomed Pharmacother 64: 472-476.
4. Attisano L, Wrana JL, Lopez-Casillas F, Massague J. 1994. TGF-beta receptors and actions. Biochim Biophys Acta 1222: 71-80.
5. Breen E, Shull S, Burne S, Absher M, Kelley J, Phan S, Cutroneo KR. 1992. Bleomycin regulation of transforming growth factor-beta mRNA in rat lung fibroblasts. Am J Respir Cell Mol Biol 6: 146-152.
6. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C. 2008. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 57: 274-282.
7. Chapman HA. 2004. Disorders of lung matrix remodeling. J Clin Invest 113: 148-157.
8. Choe JY, Jung HJ, Park KY, Kum YS, Song GG, Hyun DS, Park SH, Kim SK. 2010. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice. Inflamm Res 59: 177-188.
9. Finger EC, Turley RS, Dong M, How T, Fields TA, Blobe GC. 2008. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis 29: 528-535.
10. Fujita M, Shannon JM, Morikawa O, Gauldie J, Hara N, Mason RJ. 2003. Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. Am J Respir Cell Mol Biol 29: 669-676.
11. Gaedeke J, Noble NA, Border WA. 2004. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66: 112-120.
12. Gordon KJ, Blobe GC. 2008. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782: 197-228.
13. Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC. 2008. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 29: 252-262.
14. Han Y, Son SJ, Akhalaia M, Platonov A, Son HJ, Lee KH, Yun YS, Song JY. 2005. Modulation of radiation-induced disturbances of antioxidant defense systems by ginsan. Evid Based Complement Alternat Med 2: 529-536.
15. Hayashida T, Decaestecker M, Schnaper HW. 2003. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 17: 1576-1578.
16. Hersh CP, Hansel NN, Barnes KC, Lomas DA, Pillai SG, Coxson HO, Mathias RA, Rafaels NM, Wise RA, Connett JE, Klanderman BJ, Jacobson FL, Gill R, Litonjua AA, Sparrow D, Reilly JJ, Silverman EK. 2009. Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema. Am J Respir Cell Mol Biol 41: 324-331.
17. Hocevar BA, Brown TL, Howe PH. 1999. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. Embo J 18: 1345-1356.
18. Honda S, Akao E, Suzuki S, Okuda M, Kakehi K, Nakamura J. 1989. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Anal Biochem 180: 351-357.
19. Lasky JA, Brody AR. 2000. Interstitial fibrosis and growth factors. Environ Health Perspect 108: 751-762.
20. Lazar MH, Christensen PJ, Du M, Yu B, Subbotina NM, Hanson KE, Hansen JM, White ES, Simon RH, Sisson TH. 2004. Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin. Am J Respir Cell Mol Biol 31: 672-678.
21. Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, Yun YS. 1997. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 17: 323-331.
22. Liu M, Suga M, Maclean AA, St George JA, Souza DW, Keshavjee S. 2002. Soluble transforming growth factor-beta type III receptor gene transfection inhibits fibrous airway obliteration in a rat model of Bronchiolitis obliterans. Am J Respir Crit Care Med 165: 419-423.
23. Lopez-Casillas F, Wrana JL, Massague J. 1993. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73: 1435-1444.
24. Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS. 2004. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279: 39042-39050.
25. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16: 5353-5362.
26. Phan SH. 2002. The myofibroblast in pulmonary fibrosis. Chest 122: 286S-289S.
27. Phan SH. 2008. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 5: 334-337.
28. Selman M, King TE, Pardo A. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151.
29. Shim JY, Han Y, Ahn JY, Yun YS, Song JY. 2007. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice. Int J Immunopathol Pharmacol 20: 487-497.
30. Song JY, Han SK, Bae KG, Lim DS, Son SJ, Jung IS, Yi SY, Yun YS. 2003. Radioprotective effects of ginsan, an immunomodulator. Radiat Res 159: 768-774.
31. Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. 2005. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65: 10431-10440.
32. Wynn TA. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583-594.
33. Yano Y, Yoshida M, Hoshino S, Inoue K, Kida H, Yanagita M, Takimoto T, Hirata H, Kijima T, Kumagai T, Osaki T, Tachibana I, Kawase I. 2006. Anti-fibrotic effects of theophylline on lung fibroblasts. Biochem Biophys Res Commun 341: 684-690.